QA: Rezolute Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001509261_2021_Rezolute_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001509261, Rezolute Inc

  xvar xval
0 AssetsCurrent 10,518,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 33,000
3 remainder_Assets 414,000
4 LiabilitiesCurrent 3,226,000
5 LiabilitiesNoncurrent 165,000
6 remainder_Liabilities 209,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,959,778
9 ResearchAndDevelopmentExpense 7,848,289
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -1,423,015
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 10,965,000
1 Liabilities 3,600,000
2 Expenses 13,808,067
3 Revenues 0
4 StockholdersEquity 7,365,000
5 NetIncome -15,231,082
6 ComprehensiveNetIncome -15,231,082
7 BaseVar 14,898,041
8 EconomicCapitalRatiobeforeLimitedLiability 0.113
9 EconomicCapitalRatio 1.52

Edgar->Model Mapping

Feature Distribution

Change over Time